Myriad Genetics Inc (NASDAQ:MYGN)
| 19.16 Delayed Data As of Nov 29 |  +0.31 / +1.64%Today’s Change | 15.38 Today|||52-Week Range 28.45 | -30.58% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Diaz Paul J President & Chief Executive Officer |  Sale | 8/13/2022 | 49,980 | $27.61 | $1.4M | -31.24% |
Diaz Paul J President & Chief Executive Officer | Sale | 3/24/2022 | 26,200 | $25.32 | $663.4K | -24.29% |
Diaz Paul J President & Chief Executive Officer | Sale | 8/13/2022 | 22,370 | $27.61 | $617.6K | -31.24% |
Diaz Paul J President & Chief Executive Officer | Sale | 3/24/2022 | 17,884 | $25.32 | $452.8K | -24.29% |
Riggsbee R Bryan Chief Financial Officer | Sale | 2/18/2022 | 11,180 | $25.69 | $287.2K | -25.38% |
Hart Jayne B Chief People Officer | Sale | 2/28/2022 | 7,000 | $25.00 | $175.0K | -21.37% |
Hart Jayne B Chief People Officer |  Buy | 2/28/2022 | 7,000 | $23.98 | $167.9K | -21.37% |
Riggsbee R Bryan Chief Financial Officer | Sale | 10/09/2022 | 7,411 | $19.62 | $145.4K | +1.11% |
Lambert Nicole Chief Operating Officer | Sale | 10/09/2022 | 7,251 | $19.62 | $142.3K | +1.11% |
Riggsbee R Bryan Chief Financial Officer | Sale | 3/24/2022 | 5,323 | $25.32 | $134.8K | -24.29% |
Page of 9